Phylos Biosciences: Pioneering Natural THCV for Focus, Energy, and Wellness

Phylos Bioscience Inc.: Leading the Way in Natural THCV Research and Application

Phylos Bioscience, based in Portland, Oregon, is at the forefront of cannabis genetics and cannabinoid research, particularly with tetrahydrocannabivarin (THCV). As a rare cannabinoid, THCV is known by users to promote clean energy, focus, appetite regulation, and metabolic support, making it especially relevant for athletes, wellness enthusiasts, and consumers seeking functional cannabinoids without psychoactive effects.

Understanding THCV and Its Unique Properties

THCV is naturally occurring in select cannabis strains, many of which are cultivated by Phylos through their proprietary breeding programs. Unlike THC, THCV acts as a CB1 receptor antagonist at low doses, meaning it blocks the psychoactive effects typically associated with THC while potentially providing clear-headed stimulation, focus, and appetite regulation. At higher doses, THCV can act as a partial CB1 agonist, producing mild psychoactive effects, but still distinct from traditional THC intoxication (Pertwee et al., 2008; Riedel et al., 2009).

Phylos’ Pioneering Research

Phylos has partnered with People Science to conduct IRB-approved, double-blind clinical studies on THCV, demonstrating their commitment to rigorous, evidence-based research. Participants in these studies consumed gummies containing either a placebo, THC-only extract, or a THCV-rich extract derived from Phylos’ proprietary “Get Sh!t Done™” (GSD) strain. The results were compelling:

• Participants consuming GSD gummies reported increased energy, motivation, activity, and overall well-being with no significant increase in hunger.

• In contrast, those consuming THC-only gummies experienced fatigue three times more frequently than the THCV group.

• The study highlighted THCV’s potential to support cognitive clarity and physical performance without the drawbacks of traditional THC consumption (Phylos Biosciences, 2023).

The Advantages of Natural THCV

Phylos emphasizes naturally derived THCV over synthetic alternatives. Natural THCV is preferred for several reasons:

• Full-spectrum benefits: Naturally occurring THCV often comes with other minor cannabinoids and terpenes, creating an entourage effect that can enhance overall efficacy.

• Better safety profile: Naturally derived THCV has been studied in the context of plant-based consumption, whereas synthetic cannabinoids may carry unpredictable effects or stronger side effects.

• Sustainability: Phylos’ selective breeding and cultivation programs support responsible and reproducible production of rare cannabinoids.

Phylos’ Role in Advancing THCV

Beyond research, Phylos Biosciences is actively driving the commercialization and accessibility of THCV through their Natural™ brand. Their efforts include:

• Educating consumers and industry professionals about the unique benefits of rare cannabinoids.

• Partnering with companies like Organigram Holdings to scale seed-based production of THCV-rich strains.

• Investing in cutting-edge genetics and cultivation techniques to ensure consistency, purity, and quality.

The Phylos team, known for their expertise in genetics, biochemistry, and product development, has been instrumental in translating laboratory findings into products that are both effective and accessible. Their dedication to scientific rigor, innovation, and sustainability has positioned Phylos as a leader in the rapidly evolving cannabinoid space.

Implications for Sports, Wellness, and Beyond

The research and development conducted by Phylos suggest that THCV may provide performance, recovery, and metabolic support for athletes, as well as enhanced focus and energy for wellness-focused consumers. As interest in natural, functional cannabinoids grows, Phylos’ commitment to quality, transparency, and scientific validation ensures that THCV products meet the highest standards in both efficacy and safety.

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. THCV products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before starting any supplement routine.

References:

• Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199–215.

• Riedel G, et al. Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Eur J Pharmacol. 2009;622(1-3):61–69.

• Phylos Biosciences. (2023). IRB-Backed Controlled Research Study on the Energizing Effects of THCV. Phylos Biosciences Press Release.